ReNeuron Group plc
RNUGF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,657 | -$11,058 | -$13,410 | -$13,858 |
| Dep. & Amort. | $267 | $324 | $380 | $412 |
| Deferred Tax | $0 | $1,788 | $6,025 | -$653 |
| Stock-Based Comp. | $576 | $649 | $764 | $1,203 |
| Change in WC | -$2,648 | $1,056 | -$307 | -$857 |
| Other Non-Cash | $978 | -$170 | $496 | -$551 |
| Operating Cash Flow | -$7,484 | -$7,411 | -$6,052 | -$14,304 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$220 | -$302 | -$25 | -$119 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $4,000 | $2,500 | $0 | $0 |
| Other Inv. Act. | $131 | -$2,474 | $27 | $300 |
| Investing Cash Flow | $3,911 | -$276 | $2 | $181 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$148 | -$157 | -$154 | $6,260 |
| Stock Issued | $1 | $23 | $17,502 | $188 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $2,500 | -$8,737 | -$132 |
| Financing Cash Flow | -$147 | $2,366 | $8,611 | $6,316 |
| Forex Effect | $325 | $166 | -$483 | $167 |
| Net Chg. in Cash | -$3,395 | -$5,155 | $2,078 | -$7,807 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,548 | $14,703 | $12,625 | $20,432 |
| End Cash | $6,153 | $9,548 | $14,703 | $12,625 |
| Free Cash Flow | -$7,704 | -$7,713 | -$6,077 | -$14,423 |